Table 4. Spearman's rho correlations in patients with diabetes and non-diabetic controls.
| Patients with T1DM or T2DM (n = 121) | |||||||
| sICAM-1 | sVCAM-1 | TNFα | IL-6 | HsCRP | Haptoglobin | Adiponectin | |
| sICAM-1 | - | 0.230 (0.011) | 0.258 (0.004) | 0.297 (0.001) | 0.298 (0.001) | - | -0.199 (0.028) |
| sVCAM-1 | 0.230 (0.011) | - | - | - | - | - | - |
| TNFα | 0.258 (0.004) | - | - | 0.737 (<0.001) | 0.887 (<0.001) | 0.737 (<0.001) | -0.189 (0.038) |
| IL-6 | 0.297 (0.001) | - | 0.737 (<0.001) | - | 0.708 (<0.001) | 0.535 (<0.001) | -0.227 (0.012) |
| hsCRP | 0.298 (0.001) | - | 0.887 (0.000) | 0.708 (0.000) | - | 0.736 (0.000) | -0.189 (0.037) |
| Haptoglobin | - | - | 0.737 (0.000) | 0.535 (0.000) | 0.736 (0.000) | - | - |
| Adiponectin | -0.199 (0.028) | - | -0.189 (0.038) | -0.227 (<0.012) | -0.189 (<0.037) | - | - |
| Non-diabetic controls (n = 43) | |||||||
| sICAM-1 | sVCAM-1 | TNFα | IL-6 | HsCRP | Haptoglobin | Adiponectin | |
| sICAM-1 | - | 0.431 (0.004) | - | - | - | - | - |
| sVCAM-1 | 0.431 (0.004) | - | - | - | - | - | - |
| TNFα | - | - | - | 0.963 (<0.001) | 0.928 (<0.001) | 0.717 (<0.001) | 0.457 (0.002) |
| IL-6 | - | - | 0.963 (<0.001) | - | 0.975 (<0.001) | 0.762 (<0.001) | 0.390 (0.010) |
| hsCRP | - | - | 0.928 (<0.001) | 0.975 (<0.001) | - | 0.815 (<0.001) | 0.364 (0.017) |
| Haptoglobin | - | - | 0.717 (<0.001) | 0.762 (<0.001) | 0.815 (<0.001) | - | 0.351 (0.021) |
| Adiponectin | - | - | 0.457 (0.002) | 0.390 (0.001) | 0.364 (0.017) | 0.351 (0.021) | - |
Numbers are Spearman's rho correlation coefficients. Numbers in parentheses are significance (2-tailed). Only significant correlations are shown. sICAM-1, soluble intracellular cell adhesion molecule-1; sVCAM-1, soluble vascular cell adhesion molecule-1; TNFα, tumor necrosis factor-alpha; IL-6, interleukin-6; hsCRP, high sensitivity C-reactive protein.